Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
…, WK Chung, C Colas, SV Colonna… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide precise age-specific risk estimates of cancers other than female breast
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab …
…, KF Grossmann, S Patel, SV Colonna… - Cancer …, 2019 - Wiley Online Library
Background The optimal treatment sequence for patients with advanced BRAF V600 mutant
melanoma is unknown. BRAF/MEK inhibition (BRAF/MEKi), single agent anti‐PD‐1 (aPD‐1) …
melanoma is unknown. BRAF/MEK inhibition (BRAF/MEKi), single agent anti‐PD‐1 (aPD‐1) …
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of …
Importance The limited data on cancer phenotypes in men with germlineBRCA1 and
BRCA2pathogenic variants (PVs) have hampered the development of evidence-based …
BRCA2pathogenic variants (PVs) have hampered the development of evidence-based …
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma
JC Moser, G Wei, SV Colonna, KF Grossmann… - Acta …, 2020 - Taylor & Francis
Background: Pembrolizumab (P) and nivolumab (N) are commonly used therapies for
advanced melanoma. However, their effectiveness has never been directly compared, leaving …
advanced melanoma. However, their effectiveness has never been directly compared, leaving …
Associations of a breast cancer polygenic risk score with tumor characteristics and survival
…, JY Choi, SV Colonna… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE A polygenic risk score (PRS) consisting of 313 common genetic variants (PRS313)
is associated with risk of breast cancer and contralateral breast cancer. This study aimed …
is associated with risk of breast cancer and contralateral breast cancer. This study aimed …
[HTML][HTML] Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare …
…, PA Chan, D Chavez-Yenter, SV Colonna… - BMC health services …, 2021 - Springer
Background Advances in genetics and sequencing technologies are enabling the identification
of more individuals with inherited cancer susceptibility who could benefit from tailored …
of more individuals with inherited cancer susceptibility who could benefit from tailored …
[HTML][HTML] Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
…, SP Weinstein, D Kontos, M Woods, SV Colonna… - Breast Cancer …, 2020 - Springer
Background Background parenchymal enhancement (BPE) on breast magnetic resonance
imaging (MRI) may be associated with breast cancer risk, but previous studies of the …
imaging (MRI) may be associated with breast cancer risk, but previous studies of the …
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor
SV Colonna, L Douglas Case, JA Lawrence - Breast cancer research and …, 2012 - Springer
Women diagnosed with obesity and breast cancer have an increased risk of recurrence and
death (Protani et al., Breast Cancer Res Treat 123:627–635, 1 ). Obesity is associated with …
death (Protani et al., Breast Cancer Res Treat 123:627–635, 1 ). Obesity is associated with …
[HTML][HTML] Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor …
…, SJ Chanock, TYD Cheng, CL Clarke, SV Colonna… - Breast cancer …, 2021 - Springer
Background Given the high heterogeneity among breast tumors, associations between common
germline genetic variants and survival that may exist within specific subgroups could go …
germline genetic variants and survival that may exist within specific subgroups could go …
Analysis of risk of recurrence by subtype in≤ 1-cm breast tumors
SV Colonna, AK Higgins, J Alvarez, BR Saville… - Clinical Breast …, 2016 - Elsevier
Introduction Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer
with higher recurrence rates than other breast cancer subtypes. Increasing numbers of …
with higher recurrence rates than other breast cancer subtypes. Increasing numbers of …
